Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications
Top Cited Papers
- 27 November 2002
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA
- Vol. 288 (20) , 2579-2588
- https://doi.org/10.1001/jama.288.20.2579
Abstract
Diabetic complications are the major cause of morbidity and mortality in persons with diabetes. Chronic hyperglycemia is a major initiator of diabetic microvascular complications (eg, retinopathy, neuropathy, nephropathy). Glucose processing uses a variety of diverse metabolic pathways; hence, chronic hyperglycemia can induce multiple cellular changes leading to complications. Several predominant well-researched theories have been proposed to explain how hyperglycemia can produce the neural and vascular derangements that are hallmarks of diabetes. These theories can be separated into those that emphasize the toxic effects of hyperglycemia and its pathophysiological derivatives (such as oxidants, hyperosmolarity, or glycation products) on tissues directly and those that ascribe pathophysiological importance to a sustained alteration in cell signaling pathways (such as changes in phospholipids or kinases) induced by the products of glucose metabolism. This article summarizes these theories and the potential therapeutic interventions that may prevent diabetic complications in the presence of hyperglycemia, control of which is often difficult with current therapeutic options.Keywords
This publication has 40 references indexed in Scilit:
- Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor–betaJournal of Laboratory and Clinical Medicine, 2001
- Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetesThe FASEB Journal, 2000
- Mitogen-activated protein kinases as glucose transducers for diabetic complicationsDiabetologia, 1999
- Nephropathy in Patients with Type 2 Diabetes MellitusNew England Journal of Medicine, 1999
- d-α-Tocopherol prevents the hyperglycemia induced activation of diacylglycerol (DAG)-protein kinase C (PKC) pathway in vascular smooth muscle cell by an increase of DAG kinase activityDiabetes Research and Clinical Practice, 1999
- High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes.Diabetes Care, 1999
- Intracellular protein glycation in cultured retinal capillary pericytes and endothelial cells exposed to high-glucose concentration1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells.Diabetes, 1998
- Nonenzymatic Glycosylation and the Pathogenesis of Diabetic ComplicationsAnnals of Internal Medicine, 1984